The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

被引：0
|
作者：
W Ingram
N C Lea
J Cervera
U Germing
P Fenaux
B Cassinat
J J Kiladjian
J Varkonyi
P Antunovic
N B Westwood
M J Arno
A Mohamedali
J Gaken
T Kontou
B H Czepulkowski
N A Twine
J Tamaska
J Csomer
S Benedek
N Gattermann
E Zipperer
A Giagounidis
Z Garcia-Casado
G Sanz
G J Mufti
机构：
[1] Kings College Hospital and Kings College London,Department of Haematological Medicine
[2] The Servicio de Hematologia y Hemoterapia,Department of Haematology
[3] Hospital Universitario La Fe,Third Department of Internal Medicine
[4] Oncology and Clinical Immunology,Department of Haematology
[5] Heinrich-Heine-University,Department of Oncology and Clinical Immunology
[6] Hematology Department at Hopital Avicenne,undefined
[7] Semmelweis University,undefined
[8] University Hospital Linköping,undefined
[9] Genomics center,undefined
[10] School of Biomedical and Health Sciences,undefined
[11] Kings College London,undefined
[12] National Health Centre,undefined
[13] Semmelweis University,undefined
[14] Institute of Pathology and Cancer Research,undefined
[15] Semmelweis University,undefined
[16] St-Johannes-Hospital,undefined
来源：
Leukemia | 2006年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1319 / 1321
页数：2
相关论文
共 50 条
  • [41] JAK2 V617F Mutation Is Not Involved in Thromboembolism in IBD
    Karimi, Ouafae
    Crusius, J. Bart A.
    Coucoutsi, Constantina
    Heijmans, Roel
    Sambuelli, Alicia M.
    Pena, A. Salvador
    Koutroubakis, Ioannis E.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (11) : 1606 - 1607
  • [42] JAK2 (V617F) Mutation and Cerebral Venous Thrombosis
    Martinelli, Ida
    Passamonti, Serena Maria
    Biguzzi, Eugenia
    Franchi, Franca
    Gianniello, Francesca
    Bucciarelli, Paolo
    Pietra, Daniela
    Mannucci, Pier Mannuccio
    Cazzola, Mario
    BLOOD, 2011, 118 (21) : 1433 - 1433
  • [43] The prevalence of JAK2 V617F mutation in myelodysplastic syndrome
    Antolic, M. Radic
    Zadro, R.
    Roncevic, P.
    Kinda, S. Basic
    Labar, B.
    BLOOD REVIEWS, 2007, 21 : S126 - S126
  • [44] Absence of JAK2 V617F mutation in gastric cancers
    Lee, JW
    Soung, YH
    Kim, SY
    Nam, SW
    Park, WS
    Lee, JY
    Yoo, NJ
    Lee, SH
    ACTA ONCOLOGICA, 2006, 45 (02) : 222 - 223
  • [45] JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome
    Lin, Pei
    Luthra, Rajyalakshmi
    Nussenzveig, Roberto H.
    Medeiros, L. Jeffrey
    HUMAN PATHOLOGY, 2010, 41 (05) : 758 - 762
  • [46] Somatic mutation of the V617F JAK2 gene in patients of the cardiovascular diseases
    Olkhovskiy, I. A.
    Gorbenko, A. S.
    Stolyar, M. A.
    Grischenko, D. A.
    Tkachenko, O. A.
    Martsinkevich, T. L.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (07) : 25 - 28
  • [47] Presence of JAK2 V617F mutation in myeloproliferative and myelodysplastic syndrome patients
    Duarte, F.
    Santos, T.
    Barbosa, M.
    Santos, T.
    Goncalves, R.
    LEUKEMIA RESEARCH, 2013, 37 : S99 - S100
  • [48] Prevalence of the JAK2 V617F Mutation in Patients with Peripheral Arterial Disease
    Kinz, Elena
    Gasser, Klaus
    Muendlein, Axel
    Leiherer, Andreas
    Steurer, Michael
    Fraunberger, Peter
    Lang, Alois
    Drexel, Heinz
    BLOOD, 2014, 124 (21)
  • [49] The JAK2 V617F mutation in patients with cerebral venous thrombosis: A rebuttal
    De Stefano, Valerio
    Rossi, Elena
    Za, Tommaso
    Chiusolo, Patrizia
    Leone, Giuseppe
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (06) : 1121 - 1121
  • [50] Occurrence of JAK2 V617F mutation in patients with systemic mastocytosis and thrombocytosis
    Marie, I.
    Fu, W.
    Stoddard, J.
    Wilson, T. M.
    Metcalfe, D. D.
    Robyn, J.
    Noel, P.
    MODERN PATHOLOGY, 2008, 21 : 264A - 265A
12345